CRISPR/Cas9-Mediated Genome Editing Corrects Dystrophin Mutation in Skeletal Muscle Stem Cells in a Mouse Model of Muscle Dystrophy

Published 2017 View Full Article

Authors

Keywords

muscle stem cells, 3D fibrin gel, ex vivo expansion, CRISPR/Cas9, genome editing, Duchenne muscular dystrophy, DMD

Journal

Molecular Therapy-Nucleic Acids

Volume 7, Issue -, Pages 31-41

Publisher

Elsevier BV

Online

2017-03-01

DOI

10.1016/j.omtn.2017.02.007

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started